Related references
Note: Only part of the references are listed.A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy: Final results of the CONKO-004 trial.
H. Riess et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Role of hypoalbuminemia in the development of venous thromboembolism in cancer chemotherapy patients.
Z. Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Risk of Recurrent Venous Thromboembolism and Mortality in Patients With Cancer Incidentally Diagnosed With Pulmonary Embolism: A Comparison With Symptomatic Patients
Paul L. den Exter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer
Frederiek F. van Doormaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies
M. A. Shah et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Marcello Di Nisio et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)
A. Maraveyas et al.
EJC SUPPLEMENTS (2009)
Body fat and cardiovascular risk: understanding the obesity paradox
Felicita Andreotti et al.
EUROPEAN HEART JOURNAL (2009)
Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study
A. Delluc et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Heparin as an anticancer therapeutic
Leo R. Zacharski et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Venous thromboembolism in patients with pancreatic adenocarcinoma: Lower incidence in Asian ethnicity
So Yeon Oh et al.
THROMBOSIS RESEARCH (2008)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients
M. Mandala et al.
ANNALS OF ONCOLOGY (2007)
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
Alok A. Khorana et al.
CLINICAL CANCER RESEARCH (2007)
Anticoagulants and cancer survival
Andrea Piccioli et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
High risk of venous thrombosis in patients with pancreatic cancer: A cohort study of 202 patients
JW Blom et al.
EUROPEAN JOURNAL OF CANCER (2006)
Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma
N Nitori et al.
CLINICAL CANCER RESEARCH (2005)
Event history graphs for censored survival data
JA Dubin et al.
STATISTICS IN MEDICINE (2001)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
